tiprankstipranks
Trending News
More News >
Theriva Biologics (TOVX)
:TOVX
US Market

Theriva Biologics (TOVX) Financial Statements

Compare
1,180 Followers

Theriva Biologics Financial Overview

Theriva Biologics's market cap is currently $7.78M. The company's EPS TTM is $-0.45; its P/E ratio is -0.04; Theriva Biologics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ -87.00K$ 0.00
Operating Income$ -26.35M$ -21.43M$ -21.58M$ -14.27M$ -10.16M
EBITDA$ -19.29M$ -21.96M$ -19.20M$ -14.19M$ -9.96M
Net Income$ -25.65M$ -18.35M$ -19.68M$ -14.27M$ -10.04M
Balance Sheet
Cash & Short-Term Investments$ 11.61M$ 23.18M$ 41.79M$ 67.33M$ 6.23M
Total Assets$ 35.35M$ 55.22M$ 71.86M$ 70.36M$ 8.41M
Total Debt$ 1.56M$ 2.15M$ 1.68M$ 1.53M$ 473.00K
Net Debt$ -10.04M$ -21.02M$ -40.10M$ -65.80M$ -5.75M
Total Liabilities$ 16.29M$ 15.52M$ 17.30M$ 4.96M$ 3.15M
Stockholders' Equity$ 19.07M$ 39.70M$ 54.56M$ 65.41M$ 8.03M
Cash Flow
Free Cash Flow$ -16.94M$ -19.20M$ -19.20M$ -12.90M$ -12.18M
Operating Cash Flow$ -16.94M$ -19.00M$ -19.08M$ -12.89M$ -12.17M
Investing Cash Flow$ -1.00K$ -202.00K$ -4.40M$ -14.00K$ -9.00K
Financing Cash Flow$ 5.50M$ 625.00K$ -1.93M$ 74.00M$ 3.36M
Currency in USD

Theriva Biologics Earnings and Revenue History

Theriva Biologics Debt to Assets

Theriva Biologics Cash Flow

Theriva Biologics Forecast EPS vs Actual EPS